Mankind Pharma shareholding pattern

MANKIND

2472.6

6.60 (0.27%)
Last updated on 14 Aug, 2025 | 15:52 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Mankind Pharma Shareholding Pattern

  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

72.68%

Mutual Fund

7.34%

Insurance

2.24%

Foreign Institutional Investors

13.07%

Domestic Institutional Investors

1.88%

Retail

2.79%

Others

0%

Total Promoters
MAR '25
72.7%
JUN '25
72.68%

Mankind Pharma FAQs

As of 08-2025, the promoter shareholding in Mankind Pharma stands at 72.68% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Mankind Pharma is 13.07% and 1.88% respectively.

The retail shareholding of the Mankind Pharma is 2.79%.

Changes in shareholding patterns of Mankind Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Mankind Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.